Piloting a Multi-component Technology-based Care Intervention to Address Patient Symptoms in Home Hospice
NCT ID: NCT04243538
Last Updated: 2025-08-07
Study Results
Outcome measurements, participant flow, baseline characteristics, and adverse events have been published for this study.
View full resultsBasic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
80 participants
INTERVENTIONAL
2022-02-14
2024-10-10
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Developing and Piloting a Multi-component Technology-based Care Intervention to Address Patient Symptoms and Caregiver Burden in Home Hospice. Phase 1.
NCT04074304
Adapting and Implementing the I-HoME Intervention in Caregivers of Patients With ADRD
NCT06488157
The Hospice Advanced Dementia Symptom Management and Quality of Life Trial
NCT03681119
Developing and Testing Culturally Based Educational Videos for Puerto Rican and African American Home Hospice Caregivers
NCT06024278
Designing Care Management for Hospice Transitions for Persons Living With Advanced Dementia
NCT07182357
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Phase I of the study to assess feasibility of the intervention was registered on ClinicalTrials.gov as NCT04074304.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
SUPPORTIVE_CARE
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Control arm
Standard of care.
No interventions assigned to this group
I-HoME intervention
Weekly televisits with a nurse practitioner that will implement the I-HoME intervention.
I-HoME
I-HoME will consist of two components: (1) synchronous live video interactions between patients/CGs and a hospice nurse; and (2) educational videos.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
I-HoME
I-HoME will consist of two components: (1) synchronous live video interactions between patients/CGs and a hospice nurse; and (2) educational videos.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* English speaking
* 18 years of age or older
* not blind
* having a family member receiving home hospice care
Home hospice patients must be:
* English speaking
* 65 years of age or older
* not blind
* enrolled in home hospice care.
Exclusion Criteria
18 Years
110 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
National Institute on Aging (NIA)
NIH
Visiting Nurse Service of New York
OTHER
Weill Medical College of Cornell University
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Veerawat Phongtankuel, MD, MS
Role: PRINCIPAL_INVESTIGATOR
Weill Medical College of Cornell University
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
The Visiting Nurse Service of New York
New York, New York, United States
Countries
Review the countries where the study has at least one active or historical site.
Provided Documents
Download supplemental materials such as informed consent forms, study protocols, or participant manuals.
Document Type: Study Protocol and Statistical Analysis Plan
Document Type: Informed Consent Form
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
20-11022933frmrly19-04020138-1
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.